Hyperlipidemia refers to abnormal elevation of lipids and/or lipoprotein levels. Risks associated with this condition include stroke, peripheral vascular disease, atherosclerosis, diabetes, obesity, hypertension, and cardiovascular diseases. Drugs which are used to treat hyperlipidemia either accelerate the elimination of lipoproteins from the body or decrease production of lipoproteins. These drugs not only lower the unwanted cholesterol levels but are vital for lowering the risk of heart attacks or strokes. Primary causes of this disease include sedentary lifestyle, increase in alcohol consumption, and changes in dietary pattern. Additionally, increase in consumption of red meats, fried & processed foods, sugar, and rich foods increase blood cholesterol levels.
The global hyperlipidemia prescription drugs market is estimated to expand substantially due to rise in susceptibility to heart diseases associated with the aging population. Other factors such as patent expiration and availability of funding, undertaking of health awareness programs by health care centers, high incidence rate of cardiovascular diseases, and rising awareness among people about reducing the harmful cholesterol levels to control heart diseases are projected to drive the market during the forecast period. A large number of hyperlipidemia drugs are in phase III of clinical trials for their assessment in providing clinical benefits and long-term safety records.
Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/hyperlipidemia-prescription-drugs.html
The global hyperlipidemia prescription drugs market can be segmented based on drug class, end-user, and region. In terms of drug class, the hyperlipidemia prescription drugs market can be classified into HMG COA reductase inhibitors, fibric acid derivatives, nicotinic acids, bile acid sequestrating agents, cholesterol absorption inhibitors, and others. Based on end-user, the hyperlipidemia prescription drugs market can be categorized into hospitals and clinics. In terms of region, the global hyperlipidemia prescription drugs market can be divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The hyperlipidemia prescription drugs market in each region is sub-divided into specific countries such as the U.S., Canada, Germany, the U.K., Brazil, China, India, Japan, and GCC countries. North America dominates the global hyperlipidemia prescription drugs market, followed by Europe due to high prevalence of diseases associated with elevated levels of lipoproteins and growing baby boomer population. According to the Centers for Disease Control and Prevention (CDC), every year about 630,000 people succumb to heart diseases in the U.S. Annually 1,055,000 people in the U.S. are victims of heart attacks. Of these cases 720,000 are a first heart attack and 335,000 happen to people who have already had a first heart attack. Asia Pacific is estimated to be a highly attractive region of the market during the forecast period due to highly developed health care infrastructure, and higher adoption rate of technologically advanced therapeutic products. Additionally, rise in aging population and increase in awareness about heart disease are some factors fueling the hyperlipidemia prescription drugs market.
Key players operating in the global hyperlipidemia prescription drugs market include Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Pharmaceuticals Limited, Isis Pharmaceuticals, Inc., Merck & Co., Inc., Dr. Reddy\'s Laboratories Limited, Immuron Limited, Esperion Therapeutics, Inc., Pfizer, Inc., and Formac Pharmaceuticals N.V. Major players actively engage in various growth strategies such as collaborations, partnerships, agreements, and product launches to gain a competitive advantage in the market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1604&source=atm
The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis
The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1604&source=atm